Accès ouvert
2024
article
OpenAlex
Rebecca M. Saracino, Lee Kehoe, Michael B. Sohn, Lu Wang et autres
OBJECTIVES: Over half of new cancer diagnoses occur in patients aged 65 or older, with up to 40% experiencing anxiety. The American Society of Clinical Oncology recommends using the Generalized Anxiety Disorder Scale (GAD-7) for anxiety screening, but the GAD-7 psychometric properties …
us
(code pays fourni par la source)
2024
article
OpenAlex
Marie Flannery, Z. Zhang, E. Culakova, James D. Bearden et autres
Accès ouvert
2024
article
OpenAlex
Nikesha Gilmore, Yue Li, Christopher L. Seplaki, Michael B. Sohn et autres
BACKGROUND: Chemotherapy adversely affects physical well-being and inflammation may be related to changes in physical well-being. We evaluated the association of systemic inflammation with changes in physical well-being. METHODS: In a prospective study of 580 patients with stages I-III breast cancer we …
us
(code pays fourni par la source)
Accès ouvert
2021
article
OpenAlex
Jennifer L. Lund, Paul R. Duberstein, Kah Poh Loh, Nikesha Gilmore et autres
us
(code pays fourni par la source)
Accès ouvert
2021
article
OpenAlex
Elise J. Devlin, Hayley S. Whitford, Anita R. Peoples, Gary R. Morrow et autres
OBJECTIVE: Chemotherapy-induced nausea is challenging to predict and treat. Research indicates that pretreatment psychological variables including patients' perceptions of their susceptibility to nausea, expectancies of treatment-related nausea and nausea history (i.e., motion sickness, morning sickness and baseline levels of nausea) may aid …
au, us
(code pays fourni par la source)
Accès ouvert
2021
article
OpenAlex
Mostafa Mohamed, Kaitlin Kyi, Supriya G. Mohile, Huiwen Xu et autres
INTRODUCTION: Treatment toxicities are common in older adults with cancer and consequently, treatment modifications are sometimes considered. We evaluated the prevalence and factors associated with treatment modifications at the first cycle in older patients receiving palliative systemic treatment. METHODS: Patients (n = …
us
(code pays fourni par la source)
2021
conference-abstract
OpenAlex
Nikesha Gilmore, Elizabeth Belcher, Po‐Ju Lin, Amber S. Kleckner et autres
562 Background: Chemotherapy adversely affects the immune system and physical function. Inflammation is independently associated with functional decline. Compared to the individual cytokines [e.g., interleukin-6 (IL-6)], the pro-inflammatory index, IL-6/IL-10 ratio, is a better predictor of poor outcomes and mortality in many …
us
(code pays fourni par la source)
Accès ouvert
2020
article
OpenAlex
M.C. Liu, Geoffrey R. Oxnard, Eric A. Klein, Charles Swanton et autres
BACKGROUND: Early cancer detection could identify tumors at a time when outcomes are superior and treatment is less morbid. This prospective case-control sub-study (from NCT02889978 and NCT03085888) assessed the performance of targeted methylation analysis of circulating cell-free DNA (cfDNA) to detect and …
us, gb, ca
(code pays fourni par la source)
2019
conference-abstract
OpenAlex
Marie Flannery, Eva Culakova, Kah Poh Loh, Ronald M. Epstein et autres
11523 Background: Quality person-centered care relies on effective communication between the clinical team and the patient/caregiver eliciting goals and discussing wishes. In a PCORI- and NCI-funded CRCT, we found that providing community-based oncologists with geriatric assessment-guided recommendations led to more and higher …
us
(code pays fourni par la source)
Accès ouvert
2019
article
OpenAlex
Allison Magnuson, Lianlian Lei, Nikesha Gilmore, Amber S. Kleckner et autres
OBJECTIVES: To evaluate relationships between frailty and cognition longitudinally in adults 50 years and older with breast cancer receiving chemotherapy. DESIGN: Secondary analysis of a prospective longitudinal observational study. SETTING: University of Rochester NCI Community Oncology Research Program community oncology clinics. PARTICIPANTS: …
us
(code pays fourni par la source)
Accès ouvert
2019
article
OpenAlex
Nikesha Gilmore, Sindhuja Kadambi, Lianlian Lei, Kah Poh Loh et autres
us
(code pays fourni par la source)
2019
conference-abstract
OpenAlex
Gregory A. Vidal, Kevin Kalinsky, Erica Stringer-Reasor, Filipa Lynce et autres
Abstract Background: CB-839 is an investigational first-in-class, potent, oral inhibitor of glutaminase (GLS), a mitochondrial enzyme that controls a critical step in tumor cell utilization of glutamine. TNBC is associated with high GLS expression and depends on GLS conversion of glutamine to …
us
(code pays fourni par la source)